Vistagen Therapeutics, Inc. (VTGN)
0.6077
-0.01
(-1.07%)
USD |
NASDAQ |
Mar 06, 16:00
0.62
+0.01
(+2.02%)
After-Hours: 20:00
Vistagen Therapeutics Cash from Investing (Quarterly) : 0.104M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alector, Inc. | 25.60M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.63M |
| Cash from Financing (Quarterly) | 2.112M |
| Free Cash Flow | -60.67M |
| Free Cash Flow Per Share (Quarterly) | -0.4181 |
| Free Cash Flow to Equity (Quarterly) | -17.22M |
| Free Cash Flow to Firm (Quarterly) | -17.66M |
| Free Cash Flow Yield | -284.0% |